Valneva COVID-19 vaccine approved by MHRA 'regulatory approval' has been granted.

[link to www.gov.uk (secure)]

Valneva COVID-19 vaccine approved by MHRA
An approval has been granted after the Valneva COVID-19 vaccine was found to meet the required safety, quality and effectiveness standards.

The COVID-19 vaccine developed by Valneva has today been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).

The UK’s independent medicines regulator is the first in the world to approve the Valneva vaccine which becomes the sixth COVID-19 vaccine to be granted an MHRA authorisation.

It is also the first, whole-virus inactivated COVID-19 vaccine to gain MHRA regulatory approval. With this type of vaccine, the virus is grown in a lab and then made completely inactive so that it cannot infect cells or replicate in the body but can still trigger an immune response to the COVID-19 virus. This process is widely used already in the production of flu and polio vaccines.

What is regulatory approval?
For the purposes of clinical trials, regulatory approvals include any approvals by government or health authorities regarding any research that includes human subjects. Additional approvals will be necessary if the research involves the use of an FDA regulated product.